The national welfare Fund of Kazakhstan "Samruk-Kazyna" and the Ministry of health of the Republic signed a Memorandum on cooperation, under which the Fund has purchased and transfers to the Ministry of 100 ambulances, a thousand oxygen concentrators, 50 medical ventilators, pulse oximeters thousand, and three thousand of antiviral drugs "Aviewer," reports Sputnik Kazakhstan.
In the framework of the Memorandum "Samruk-Kazyna" will also cooperate with the Ministry of health of Russia with the aim to provide Kazakhstan with the necessary drugs to fight the pandemic.
The Russian direct investment Fund (RDIF) and the national welfare Fund of Kazakhstan "Samruk-Kazyna" JSC have agreed to cooperate in the fight against coronavirus and discuss the possibility of localization of production of the Russian vaccine in Kazakhstan, the message reads RDIF.
RDIF and "Samruk-Kazyna" signed a Memorandum on cooperation for combating coronavirus infection. Under the agreement, RDIF has already made Kazakhstan the first batch of the drug against the coronavirus, "Avidavit". In addition, the FUND "Samruk-Kazyna" JSC have agreed to cooperate in clinical trials, sourcing and manufacturing of a vaccine against coronavirus.
The head of the Russian direct investment Fund Kirill Dmitriev has denied the charges of London in an attempt to steal information about the development of a vaccine against coronavirus.
Earlier in the British cyber security centre said that over the years, hackers have carried out attacks on various organizations that participated in the creation of the drug from COVID-19. In London believe that the perpetrators "almost certainly" relate to the Russian intelligence service.
The Russian direct investment Fund (RDIF) in July is awaiting authorization for outpatient treatment from the coronavirus "Aviewer", after it can appear in pharmacies on prescription, told reporters the head of RDIF Kirill Dmitriev.
"It is important to understand that there is an important fact - not the drug to use for pregnant women and during pregnancy planning. This is a very well known fact about this drug, we are openly talking about it. It is therefore very important that when people will get in the pharmacies, they will get the prescription, and the doctor is obliged to talk to them, that they will not plan for your family during the adoption preparation", - he stressed.
The Russian direct investment Fund (RDIF) sees possibilities for the production of Russian medicines in the fashion industry, "Aviewer" Cuba, go discussions, told reporters the head of RDIF Kirill Dmitriev.
"Cuba is very strong pharmaceuticals. We are in contact with Cuban colleagues, including our drug "Avidavit". We would love to have this preparation was done in Cuba," - said Dmitriev.
The drug from COVID-19 "Coronaves" sent to the Russian hospital, said RIA Novosti in the press service of the producer "R-Pharm".
"7374 packaging marked drug "Coronaves" came into circulation with the Yaroslavl plant "R-Pharm", - told in the company, adding that the drugs sent to the Russian hospital.
A number of Latin American countries, Saudi Arabia and Bulgaria has purchased Russian drug for the treatment of a coronavirus, "Aviewer", said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"Aviewer" production RDIF and Chemrar may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains the active substance "Favipiravir", and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. "Aviewer" has proven its effectiveness in clinical trials and blocking mechanisms for the propagation of the coronavirus.
The government of Mexico intends to contact the authorities of Russia on the acquisition of the antiviral drug "Aviewer", said the President of the Republic Andres Manuel Lopez Obrador.
"Gladly received the proposal of the Russian government and intends to begin negotiations. The Minister of foreign Affairs aware of this proposal and is going to contact the authorities of Russia", - said the President during a press conference which is published in his microblog on Twitter.
Regulatory approval of the vaccine for coronavirus is expected in August and September, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"We are now actively working to start vaccine Institute Gamalei. Believe that is certainly extremely important. ...We believe that regulatory approval of the vaccine will be already in August-September," - said Dmitriev on air of TV channel "Russia 1".
Russian anti-coronavirus "avitamin a" better American "Ramdevpir", it is cheaper and comes in tablets, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"Aviewer", in which participated the FUND, may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains active substance favipiravir, and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. RDIF has asked the health Ministry to allow the use of "Avifauna" outpatient those treated for the coronavirus of the house.
Brazil and Latin America, which sharply increases the number of people infected with coronavirus, the first to receive the drug "Aviewer," said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
"We have received a request from more than 50 countries, and definitely a priority for us are those countries where sharply increasing number of coronavirus infections. This, of course, Brazil and many other Latin American countries," said Dmitriev in an interview via Skype on the channel "Russia 1".
Drug "Aviewer" from COVID-19 was applied successfully to treat more than 30 of thousands of Russians in different regions, from the presentation of the company "Chromis", which is the manufacturer of the drug.
"Aviewer" was effectively used by more than 30 thousands of Russian patients in 51 regions of the country", - the document says.
The results of studies in Japan "by Favipiravir" which is used in Russia for the treatment of coronavirus, are preliminary and do not allow to make definite conclusions about the effectiveness or ineffectiveness of the drug, said the Chairman of the Board of Directors of "Khimrar" Andrey Ivashchenko.
Agency Kyodo earlier reported that the specialists of the Institute of public health Fujita on the results of clinical trials of the drug "Avigan" ("Favipiravir", "Failover") could not confirm its effectiveness. The Russian direct investment Fund (RDIF) and Chemrar produce a drug called "Aviewer" in Russia.
The Russian Embassy in Guatemala, together with the Russian direct investment Fund (RDIF) on 10 July, will hold a presentation of the drug against the coronavirus, "Aviewer" for Latin America and the Caribbean, it has already signed up about 800 people, reported RIA of news in Embassy.
"The development of the theme of the fight against coronavirus Embassy jointly with the company "Kramis", "Khimrar" and the FUND, vyvedshie on the Russian market the drug against the coronavirus, "Aviewer", organizes his presentation in Latin America and the Caribbean. To participate in the conference invited representatives of all supranational parliaments of the region, relevant agencies and committees," said the Embassy.
The drug from COVID-19 "Coronaves" will be sent to the hospitals of Moscow, St.-Petersburg, Yaroslavl and other regions after receiving a registration certificate, said RIA Novosti in the pharmaceutical companies "R-Pharm".
The third Russian drug from COVID-19 international non-proprietary name favipiravir received the approval of the Ministry of health. Trade name of the drug is "Cornavin" producer company "R-farm", to information in the state register of medicines. The first drug on the basis of favipiravir was approved in late may, this "Aviewer" production RDIF and "Chimera". The second "Replevin" company "Promomed" in June. All drugs have a temporary registration until January 1, 2021.
The Russian direct investment Fund (RDIF) and a group of companies "Chemrar" began to supply the drug for the treatment of a coronavirus, "Aviewer" for export, in June he was sent to Belarus in the near future expected deliveries to Kazakhstan, the report said Fund.
"RDIF and a group of companies "Chemrar" announce the production in June, the first 100 thousand Russian courses of the drug against the coronavirus, "Aviewer", which is significantly higher than the original production plan at the level of 60 thousand courses", - stated in the message.
The demand for shares in Detskiy Mir, the largest Russian retailer of children's goods, from foreign and Russian investors has exceeded the offer five times, more than 60% of the order book was signed by international funds from Europe, America and Asia, said the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
Sistema and the Russian-Chinese investment Fund (RCIF established by the Russian direct investment Fund and China Investment Corporation) on Wednesday reported a successful SPO of the shares "Children's world". And RCIF sell of 15.94% of the shares will receive the securities order 10,953 billion. Share AFK "System" in the retailer after posting will be reduced to 20.38% from 33,38%, RCIF - to 4.62% from 7.56% in the aggregate they will retain 25% plus one share of the company.
Mobile medical teams in field hospitals of the Ministry of defense of Russia began to test the population of Dagestan on COVID-19 in remote areas of the Republic using the latest mobile laboratories, according to the Ministry of defence.
Earlier it was reported that the mobile laboratory was delivered to the Republic of the Russian direct investment Fund (RDIF), with the assistance of the Ministry of defense of Russia. They have been used successfully by Russian military doctors at the field hospital in the Italian Bergamo.
The first batch of a medicinal product for the treatment of COVID-19 "Aviewer" arrived in Nizhny Novgorod oblast, the press service of the regional government.
Earlier it was reported that the Russian direct investment Fund (RDIF) and a group of companies "Chemrar" began to supply the drug against the coronavirus, "Aviewer" in hospitals of Moscow, Leningrad, Novgorod, Kirov, Nizhny Novgorod regions, the Republic of Tatarstan and Ekaterinburg.
Holding "national immunobiological company" the state Corporation "rostec" and the Russian direct investment Fund (RDIF) will begin to release drug based on blood plasma for the treatment of COVID-19, production is scheduled to deploy immediately on four grounds stated in the joint message of the companies.
"The partnership between RDIF and holding "national immunobiological company" involves the production of an immunoglobulin preparation that contains antibodies to the coronavirus SARS CoV-2. It will be made on the basis of plasma donors who have had coronavirus infection", - stated in the message.
The Russian direct investment Fund (RDIF) and a group of companies "Chemrar" said the frequent cases of fraud with the sale of drugs with the active ingredient favipiravir - these drugs it is impossible to buy, the report said Fund.
RDIF and Chemrar stressed that at the present time on the territory of the Russian Federation a legal purchase of drugs on the basis of favipiravir Japanese or Chinese production is impossible in the absence of official supply of the drug from abroad.
Russian President Vladimir Putin discussed with the head of RDIF Kirill Dmitriev combating coronavirus and the establishment of test systems.
The President began a meeting with Dmitriev with the most relevant, according to him, the theme of the fight against the spread of coronavirus.
Russia manages to maintain the macroeconomic situation in the country at a good level, the inflation is kept within the parameters, and unemployment, though older, but not as dramatic as in other countries, said Russian President Vladimir Putin.
"Macroeconomics we are able to keep in working condition, very good quality level," Putin said at a meeting with head of the Russian direct investment Fund (RDIF) Kirill Dmitriev.
The Russian direct investment Fund (RDIF) and the RTP Global funds, Elbrus Capital, and Baring Vostok has set up a joint investment platform with the volume up to $ 200 million, which will support promising Russian companies affected by the impact of the pandemic coronavirus, the report said RDIF.
"The FUND, a sovereign Fund of the Russian Federation, and funds of RTP Global, Elbrus Capital, and Baring Vostok announced the creation of a joint investment platform with the volume up to $ 200 million. The platform will provide support for promising Russian companies in a wide range of industries that experienced negative effects of the pandemic coronavirus", - stated in the message.
The US supplies of ventilators in Russia are a perfect example of cooperation between the two countries in difficult times, said the official representative of Russian foreign Ministry Maria Zakharova.
"I think it's a great example of how a very difficult situation for countries to establish cooperation, partnership and cooperation," Zakharova said at the briefing.
World health organization aware of the registration of the first Russian drugs to treat coronavirus "Aviewer", want to learn more about the tests, said at a briefing on Wednesday, chief Executive officer, who Sumia Swaminathan.
Russia's first drug against COVID-19 "Aviewer" production RDIF and Chemrar has received approval from the Ministry of health. In early June the first batch of "Avifauna" will be sent to the Ministry for opinion on issuance.
The Chairman of the security Council of the Russian Federation, the Chairman of the Board of Trustees of Fund "SKOLKOVO" Dmitry Medvedev is counting on the efficiency of the Russian drug "Aviewer", intended for the treatment of coronavirus.
The Ministry of health previously included the drug "Avidavit" (based on favipiravir) of production of the Russian direct investment Fund (RDIF) and Chemrar in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. The registration certificate was received by the company "Chromis", resident of the biomedical technologies cluster Fund "SKOLKOVO".
"Aviewer" can arrive in the Russian hospital on June 11, the newspaper "Izvestia" with reference to the Russian direct investment Fund (RDIF).
The implementation of the drug will occur in contracts with health facilities, so it will not work in the free market, the newspaper notes. It is emphasized that to appoint the drug will be only in hospitals under the supervision of doctors.
Russia's first drug against COVID-19 received the approval of the Ministry of health, follows from the information in the state register of medicines.
"Trade name of the drug is "Avidavit". Or modified international nonproprietary or chemical name, the "Favipiravir", — stated in the list.
